Christian Van Hoecke

Author

Also Known As

C Van Hoecke, C. Hoecke, C. Van Hoecke, Christian Hoecke, Christian Van Hoecke, Christian Van Hoecke, Christian van Hoecke

Publications

900

Citations

H-Index

Concepts

All Affiliations

New Frontier GlaxoSmithKline (Belgium)Jan Evangelista Purkyně Military Medical Academy Connecticut Children's Medical Center GlaxoSmithKline (United Kingdom)

About

Christian Van Hoecke is an author at New Frontier specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	267
2	Immunology	5	5	204
3	Autoimmune Disease	2	2	68
4	Epidemiology	1	1	63
5	Autoimmunity	1	1	55

Christian Van Hoecke

Publications

890

Citations

H-Index

Page 1

	Year	Citations
Serum Antibody Responses after Intradermal Vaccination against Influenza Robert B. Belshe, Frances K. Newman, Joan C. Cannon, New England Journal of Medicine	2004	330
Potent Induction of Focused Th1‐Type Cellular and Humoral Immune Responses by RTS,S/SBAS2, a Recombinant<i>Plasmodium falciparum</i>Malaria Vaccine Ajit Lalvani, Phillipe Moris, Gérald Voss, The Journal of Infectious Diseases	1999	155
Ten Years of Experience with the Trivalent Split-Influenza Vaccine, Fluarix??? Norbert Hehme, Walter K nzel, Frank Petschke, Clinical Drug Investigation VaccinationVaccine SafetyCross-protectionPreventive MedicineVaccine Efficacy	2002	63
A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320 Sheena McCormack, AntheaJ. Tilzey, A.J. Carmichael, Vaccine Primary ImmunodeficiencyHuman RetrovirusImmunologyAntiviral TherapyAntiviral Response	2000	57
Alternative Vaccination Schedules (0, 1, and 6 Months Versus 0, 1, and 12 Months) for a Recombinant OspA Lyme Disease Vaccine Christian Van Hoecke, E. Lebacq, Jiřı́ Beran, Clinical Infectious Diseases Healthy SubjectsLyme Disease VaccineImmunodeficienciesImmunologyImmunotherapy	1999	55
Immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children Henry M. Feder, Christian Van Hoecke, Betsy Abraham, The Journal of Pediatrics VaccinationVeterinary VaccineVaccine DevelopmentImmunologyInfection Control	1999	45
A Single Dose, Combined Vaccine against Typhoid Fever and Hepatitis A: Consistency, Immunogenicity and Reactogenicity Jiřı́ Beran, M. Beutels, Karin Levie, Journal of Travel Medicine	2006	43
Safety and Immunogenicity of a Recombinant <i>Borrelia burgdorferi</i> Outer Surface Protein A Vaccine Against Lyme Disease in Healthy Children and Adolescents: A Randomized Controlled Trial Vijay K. Sikand, Neal A. Halsey, Peter J. Krause, PEDIATRICS	2001	40
Concomitant Vaccination against Hepatitis A and Typhoid Fever Christian Van Hoecke, E. Lebacq, Roman Prymula, Journal of Travel Medicine	1998	34
Safety and immunogenicity profile of a recombinant outer-surface protein a Lyme disease vaccine: Clinical trial of a 3-dose schedule at 0, 1, and 2 months Robert T. Schoen, Vijay K. Sikand, Michael C. Caldwell, Clinical Therapeutics VaccinologyVaccinationVaccine DevelopmentLyme Disease VaccineImmunology	2000	34

Page 1